These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21178437)

  • 41. The paradox of the immune response in HIV infection: when inflammation becomes harmful.
    Ipp H; Zemlin A
    Clin Chim Acta; 2013 Feb; 416():96-9. PubMed ID: 23228847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Microbial translocation in HIV infection].
    Oleksiuk J; Grzeszczuk A
    Pol Merkur Lekarski; 2014 Dec; 37(222):353-5. PubMed ID: 25715577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the study power enough to say "no difference"?
    Geib G; Debiasi M; Barcellos NT; Wolff FH
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):e37; author reply e37-8. PubMed ID: 21921724
    [No Abstract]   [Full Text] [Related]  

  • 44. Desensitization to type I interferon in HIV-1 infection correlates with markers of immune activation and disease progression.
    Hardy GA; Sieg SF; Rodriguez B; Jiang W; Asaad R; Lederman MM; Harding CV
    Blood; 2009 May; 113(22):5497-505. PubMed ID: 19299650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual.
    Shah T; Lampiris H; Vu M; Monto A; Tien PC
    J Infect Dis; 2008 Mar; 197(6):932-3. PubMed ID: 18419352
    [No Abstract]   [Full Text] [Related]  

  • 46. Type I Interferons in NeuroHIV.
    Thaney VE; Kaul M
    Viral Immunol; 2019; 32(1):7-14. PubMed ID: 30260742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune complexes that contain HIV antigens activate peripheral blood T cells.
    Korolevskaya LB; Shmagel KV; Saidakova EV; Shmagel NG; Chereshnev VA
    Dokl Biol Sci; 2016 Jul; 469(1):196-8. PubMed ID: 27595830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early immune senescence in HIV disease.
    Desai S; Landay A
    Curr HIV/AIDS Rep; 2010 Feb; 7(1):4-10. PubMed ID: 20425052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections".
    Menu E; Müller-Trutwin MC; Pancino G; Saez-Cirion A; Bain C; Inchauspé G; Gras GS; Mabondzo AM; Samri A; Boutboul F; Le Grand R
    Retrovirology; 2005 Apr; 2():24. PubMed ID: 15813969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacterial translocation: a useful biomarker for immune activation and disease progression.
    Bentwich Z
    AIDS; 2011 Jul; 25(11):1439-41. PubMed ID: 21712658
    [No Abstract]   [Full Text] [Related]  

  • 51. Persistent immune activation in chronic HIV infection: do any interventions work?
    Rajasuriar R; Khoury G; Kamarulzaman A; French MA; Cameron PU; Lewin SR
    AIDS; 2013 May; 27(8):1199-208. PubMed ID: 23324661
    [No Abstract]   [Full Text] [Related]  

  • 52. Study design may explain discrepancies in GB virus C effects on interferon-γ and interleukin-2 production and CD38 expression in T lymphocytes.
    Bhattarai N; Stapleton JT
    Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):568-9; author reply 569. PubMed ID: 22666874
    [No Abstract]   [Full Text] [Related]  

  • 53. From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection.
    Koethe JR; Heimburger DC; PrayGod G; Filteau S
    J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S75-82. PubMed ID: 27625434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hepatitis C, HIV infection and delay in diagnosis].
    Alastrué Loscos JI; Giner Valero M
    Aten Primaria; 2002 Dec; 30(10):666; author reply 666-7. PubMed ID: 12525350
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to Mandorfer et al.
    Hull MW; Rollet K; Klein MB;
    Clin Infect Dis; 2013 Mar; 56(6):905-6. PubMed ID: 23243174
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients.
    Emmanuel B; El-Kamary SS; Magder LS; Stafford KA; Charurat ME; Poonia B; Chairez C; McLaughlin M; Hadigan C; Masur H; Kottilil S
    Hepatol Int; 2019 May; 13(3):270-276. PubMed ID: 30835046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
    Billa O; Chalouni M; Salmon D; Poizot-Martin I; Gilbert C; Katlama C; Neau D; Chas J; Morlat P; Lacombe K; Naqvi A; Barange K; Gervais A; Bouchaud O; Rosenthal E; Lascoux-Combe C; Garipuy D; Alric L; Dominguez S; Vittecoq D; Goujard C; Duvivier C; Aumaitre H; Miailhes P; Zucman D; Simon A; Lazaro E; Raffi F; Esterle L; Wittkop L; Bani-Sadr F;
    PLoS One; 2018; 13(12):e0208657. PubMed ID: 30562358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.
    Kallas E; Huik K; Türk S; Pauskar M; Jõgeda EL; Šunina M; Karki T; Des Jarlais D; Uusküla A; Avi R; Lutsar I
    Viral Immunol; 2016 Oct; 29(8):464-470. PubMed ID: 27564643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
    Wang L; Zhao J; Ren JP; Wu XY; Morrison ZD; Elgazzar MA; Ning SB; Moorman JP; Yao ZQ
    AIDS; 2016 Jun; 30(10):1521-1531. PubMed ID: 26959508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.